These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20107446)

  • 1. Why change is needed in research examining dietary supplements.
    Tsourounis C; Bent S
    Clin Pharmacol Ther; 2010 Feb; 87(2):147-9. PubMed ID: 20107446
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug safety. IOM recommends action on dietary supplements.
    Stokstad E
    Science; 2004 Apr; 304(5668):188. PubMed ID: 15073343
    [No Abstract]   [Full Text] [Related]  

  • 3. Dietary supplements: a call to action.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):330-2. PubMed ID: 21133740
    [No Abstract]   [Full Text] [Related]  

  • 4. Public health. Toward evidence-based health claims for foods.
    Katan MB; de Roos NM
    Science; 2003 Jan; 299(5604):206-7. PubMed ID: 12522235
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
    Frankos VH; Street DA; O'Neill RK
    Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correcting regulatory chaos: is there light at the tunnel's end?
    Marty AT
    J Altern Complement Med; 2003 Aug; 9(4):459. PubMed ID: 14499019
    [No Abstract]   [Full Text] [Related]  

  • 7. Nutraceuticals and functional foods regulations in the United States and around the world.
    Bagchi D
    Toxicology; 2006 Apr; 221(1):1-3. PubMed ID: 16487648
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure/function claims in dietary supplement labeling: not all of these claims need to be submitted to FDA and accompanied in labeling by the DSHEA disclaimer.
    McNamara SH
    Food Drug Law J; 1999; 54(1):35-42. PubMed ID: 11758558
    [No Abstract]   [Full Text] [Related]  

  • 9. Maintaining a level playing field: the need for a uniform standard to evaluate health claims for foods and dietary supplements.
    Pappas CD
    Food Drug Law J; 2002; 57(1):25-41. PubMed ID: 12118479
    [No Abstract]   [Full Text] [Related]  

  • 10. Nutrition labeling: issues and directions for the 1990s.
    Earl R; Porter DV; Wellman NS
    J Am Diet Assoc; 1990 Nov; 90(11):1599-601. PubMed ID: 2229858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary supplements and lessons to be learned from GRAS.
    Burdock GA
    Regul Toxicol Pharmacol; 2000 Feb; 31(1):68-76. PubMed ID: 10715226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Science and government. Review for NCCAM is overdue.
    Marcus DM; Grollman AP
    Science; 2006 Jul; 313(5785):301-2. PubMed ID: 16857923
    [No Abstract]   [Full Text] [Related]  

  • 13. So you want to market a food and to make health-related claims--how far can you go? What rules of law will govern the claims you want to make?
    McNamara SH
    Food Drug Law J; 1998; 53(3):421-36. PubMed ID: 10346720
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA has substantial and sufficient authority to regulate dietary supplements.
    McNamara SH; Siegner AW
    Food Drug Law J; 2002; 57(1):15-24. PubMed ID: 12118477
    [No Abstract]   [Full Text] [Related]  

  • 15. From aspartame to Xenical. A look at the FDA review process.
    Trissler RJ
    J Am Diet Assoc; 1999 Jul; 99(7):797-8. PubMed ID: 10405675
    [No Abstract]   [Full Text] [Related]  

  • 16. IOM: overhaul drug safety monitoring.
    Kuehn BM
    JAMA; 2006 Nov; 296(17):2075-6. PubMed ID: 17077364
    [No Abstract]   [Full Text] [Related]  

  • 17. IOM advises FDA on ethics in postmarket safety trials.
    Kuehn BM
    JAMA; 2010 Aug; 304(6):627. PubMed ID: 20699450
    [No Abstract]   [Full Text] [Related]  

  • 18. Trial and error: should pregnant women be research subjects?
    Kornblum A
    Environ Health Perspect; 1994 Sep; 102(9):752-3. PubMed ID: 9657705
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of dietary supplements: FDA's strategic plan.
    Levitt JA
    Food Drug Law J; 2002; 57(1):1-13. PubMed ID: 12118474
    [No Abstract]   [Full Text] [Related]  

  • 20. Protection of children and risks with medical devices.
    Maloney DM
    Hum Res Rep; 2004 Dec; 19(12):3. PubMed ID: 15810178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.